AI Tool May Aid Remote Assessment of Parkinson Symptom Severity
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Sept. 18, 2023 -- An artificial intelligence tool can help remotely assess the severity of Parkinson disease symptoms, according to a study published online Aug. 23 in npj Digital Medicine.
Saiful Islam, from the University of Rochester in New York, and colleagues developed an artificial intelligence system to remotely assess the motor performance of individuals with Parkinson disease. The analysis included 250 global participants (172 with Parkinson disease and 78 controls) who performed a standardized motor task involving finger-tapping with each hand in front of a webcam. Overall, 489 videos were analyzed (244 videos for the left hand and 245 for the right hand). Severity of Parkinsonian symptoms diagnosed by the finger-tapping task was compared to three expert neurologists' ratings.
The researchers found that interrater reliability was excellent, with an intraclass correlation coefficient of 0.88. The machine learning model trained on these measures outperformed two certified raters of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (mean absolute error [MAE], 0.58 points versus raters' average MAE of 0.83 points). However, expert neurologists (0.53 MAE) slightly outperformed the model.
"The methodology can be replicated for similar motor tasks, providing the possibility of evaluating individuals with Parkinson disease and other movement disorders remotely, objectively, and in areas with limited access to neurological care," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.